Startups
Biosimilars Council, a division of Association for Accessible Medicines, works to ensure a positive
Overview
Location
United States, Washington
Employees
11-50
Phone
+1 202-249-7100
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 8, 2022 | Generic drug manufacturers say Democrats' drug bill could lead to higher prices | (The Center Square) – Generic drug manufacturers oppose Democrats’ bill allowing Medicare to negotiate drug prices. The Senate passed its climate, tax, and healthcare bill on Sunday, which permits Medicare to negotiate what it pays for drug... |
| Dec 15, 2021 | This Holiday Season, Let’s Appreciate the Difference Health Makes | (BPT) - The new year invites us to recognize what’s really important. As many families gather for the first holiday season back together, the value of health takes precedence over the packages under the tree. And as we make our resolutions,... |
| Mar 6, 2020 | Five years on, biosimilars need support from all health care players | Today marks a milestone for the U.S. biosimilar market: the FDA approved our first biosimilar, Sandoz’s Zarxio, five years ago, on March 6, 2015. The biosimilar category holds incredible promise, and the market for these products is on an u... |
| May 9, 2018 | Games and greed delay the market entry of money-saving biosimilars | Generic medicines have saved Americans $1.67 trillion in the last decade. Biosimilars, which are more affordable, highly similar, safe, and effective versions of complex biologic medicines, are poised to do the same thing — if they aren’t t... |
| Are biosimilars the next frontier in drug development? | A conversation on reducing costs Biological products are the fastest growing class of therapeutic products in the U.S.1 Biosimilars are biological products that are highly similar to a reference product in terms of structure and function an... |
Reviews 0
FAQ about Biosimilars Council
What has the press written about Biosimilars Council?
Parsers VC has collected 6 articles mentioning Biosimilars Council, among them “Generic drug manufacturers say Democrats' drug bill could lead to higher prices” (Aug 8, 2022) and “This Holiday Season, Let’s Appreciate the Difference Health Makes” (Dec 15, 2021).
Is Biosimilars Council still active?
Yes, Biosimilars Council is active; its latest activity on Parsers VC dates from Sep 2, 2025.